A new series of quinoxaline 1,4-di-N-oxides were synthesized and evaluated for their antibacterial and antifungal activities. The best result was demonstrated by 3-amino-N-(4-methoxyphenyl)-2-quinoxalinecarboxamide 1,4-di-N-oxide 4e, MIC (0.24 µg/ml) against Aspergillus fumigatus, and (0.12 µg/ml) against Streptococcus pneumonia.
Introduction
There is a growing need to develop new antibacterial agents in order to overcome the emergence of bacterial resistance to antibiotic therapy. Quinoxaline 1,4-di-Noxide is a nucleus that displays a wide range of activities. Quinoxaline 1,4-di-N-oxides and their derivatives demonstrated excellent activities as antibacterial [1] [2] [3] [4] [5] , antiplasmodial [2, 6, 7] , antifungal [8] and as antimycobacterial [9] [10] [11] [12] [13] . Encouraged by these reported activities and with the aim of searching for new, broad spectrum and more potent antimicrobial compounds which can improve the current chemotherapeutic treatments, 20 new quinoxaline 1,4-di-Noxide derivatives were synthesized and evaluated. In most of the quinoxaline 1,4-di-N-oxides reported as antibacterial and/or antimycobacterial, the carboxamide in position 2 was a common feature [11, 13] . Therefore, the newly synthesized compounds 3a-n possessed a carboxamide in position 2 that was substituted with various aryl moieties bearing both electron-withrawing and electron donating groups. This series of quinoxaline carboxamide was prepared from unsubstituted benzofuroxane, 3a-g to be compared to their 7-chloro counterparts 3h-n in order to study the effect of substitution of chlorine atom in position 7.
Results and Discussion

Chemistry
The synthetic route for the preparation of the quinoxaline 1,4-di-N-oxide were obtained by the Beirut reaction [14, 15] . This reaction, which has been referred to as the Beirut reaction, is an excellent method for preparing these heterocyclic compounds. Benzofuroxanes 1a,b were obtained by previously described methods [13, 16] . Thus, the appropriate BFO reacted with the corresponding β-ketoamide (2a,b) or β-cyanoamide (3a-n) in the presence anhydrous potassium carbonate as a catalyst (Scheme 1). The use of inorganic catalyst for this reaction provided better means of purification with considerably good yields, whereas the reaction of BFO with cyanoacetamide was better carried out using triethylamine as a catalyst and dimethylfomamide as the solvent. These two intermediates, β-ketoamide and β-cyanoamide, were prepared by condensation of either ethylacetoacetate or ethylcyanoacetae with different amines [11, 12, 17] . When the target compounds were prepared from monosubstituted-BFO, the formation of isomeric quinoxaline 1,4-di-N-oxides was observed. In most cases, the 7-substituted isomer prevailed over 6-substituted isomer, and when the methoxy substituted quinoxalines were prepared, only the 7-isomer was obtained, as previously described [18, 19] .
Moreover, in order to investigate the antimicrobial activity of fused tricyclic and tetracyclic di-N-oxides derived from quinoxaline 1,4-di-N-oxide the phenazine derivative 5 and the indenoquinoxaline 6 were synthesized. The Beirut reaction was similarly followed using cyclic diketones such as indandione or dimidone. All the prepared compounds were characterized in light of their microanalysis and spectral data including IR, 1 H NMR and mass spectrum.
Microbiology
The newly synthesized compounds were tested for their antibacterial and antifungal activities. These assays were performed at the Regional Center for Mycology and Biotechnology, Antimicrobial unit test organisms, Cairo, Egypt. Compounds 4i and 4k were previously synthesized [17] but they were prepared again in order to perform the microbiological testing on them and compare them to their unsubstituted counterparts. The tested compounds were evaluated for their antifungal activity against (Aspergillus fumigatus (RCMB 02568), Syncephalastrum racemosum (RCMB 05922), Geotricum candidum (RCMB 05097) Candida albicans (RCMB 05036)). The antibacterial activity was evaluated against (Gram positive: Streptococcus pneumonia (RCMB 010010), Bacillis subtilis (RCMB 010067)) and Gram negative (Pseudomonas aeruginosa (RCMB 010046), Escherichia coli (RCMB 010052)). Amphotericin B was taken as a reference for the antifungal effect, while ampicillin was the standard used for the evaluation of antibacterial activity against gram positive bacteria and gentamicin was used as a standard in assessing the activity of the tested compounds against gram negative bacteria. The results expressed as the mean zone of inhibition in mm ± standard deviation beyond well diameter (6 mm) produced on the microorganisms using (10 mg/ml) concentration of tested samples, shown in Table 1 .
The initial screening of the tested compounds showed promising activity of some of the compounds which encouraged the determination of their minimum inhibitory concentration (MIC) ( Table 2) . The best results were demonstrated by compound 4e both as antifungal and against gram positive bacteria, it possessed double the activity of the standard, amphotericin B against Aspergillus fumigatus, (0.24 and 0.49 µg/ml, respectively)and ampicillin against Streptococcus pneumonia (0.12 and 0.24 µg/ml, respectively). This compound has also displayed 4 times the activity of amphotericin B against Syncephalastrum racemosum, (7.81, 1.95 µg/ml, respectively). Other derivatives also possessed remarkable activity against Syncephalastrum racemosum as 4i which displayed double the inhibitory effect of the standard (3.9, 7.81 µg/ml, respectively), while 2a and 6 were as active as the amphotericin B. Moderate activity against gram positive bacteria Streptococcus pneumonia was also demonstrated by compounds 3b and 6. However, this series of compounds had no effect on Candida albicans and were also ineffective against gram negative bacteria. Moreover, compounds 2b, 4g, 4k and 5 showed no activity against most of the tested strains. A simple SAR study reveals certain features that could improve the activity such as the amino group in position 3, quinoxaline unsubstituted in position 6, the electrondonating substituents on the phenyl amino displayed better effect than electron withdrawing. As for the fused derivatives the tetracyclic indenoquinoxaline 6 was better than the tricyclic phenazine 5.
Conclusion
In this study, certain novel quinoxaline 1,4-di-N-oxide derivatives were synthesized and evaluated for their antbacterial and antifungal activities. Melting points were determined by using melting point apparatus and are uncorrected. MS spectra were obtained on a GC Ms-QP 1000 EX mass spectrometer at 70 eV. Microanalyses were performed using a C H N S/O analyzer. Elemental data are within ±0.4% of the theoretical values. All yields reported areunoptimized. The chemical reagents used in synthesis were purchased from Fluka, Sigma and Aldrich.
General Procedure for Preparation of
Compounds 2a,b A warm solution of 5(6)-benzofuroxane 1a,b and the appropriate acetoacetanilide (0.01 mol) in ethanol (50 mL) was stirred at room temperature in the presence of catalytic amount of potassium carbonate. The yellow products precipitated over a period of 2 -4 h. The residual product was triturated with water, extracted with ethylacetate then the organic solvent was dried over anhydrous sodium sulphate and removed in vacuo to give yellow crystals that were recrystallized out from ethanol.
1) 2-N-(4-Fluorophenyl)-3-methyl-2-quinoxaline carboxamide 1,4-di-N-oxide 2a.
Yield (78%); mp 221˚C. IR (KBr, cm 
General Procedure for Preparation of
Compounds 3a,b A mixture of 5(6)-substituted benzofuroxane 1a,b and cyanoacetamide (0.01 mol) was stirred for 10 min at 0˚C. Over the cooled suspension, a solution of triethylamine (5 drops) in dimethylformamide was added. The mixture was allowed to stand at room temperature over 24 h and then filtered off. The red solid product was filtered and recrystallized from ethanol. 
Compounds 4a-n A warm solution of 5(6)-benzofuroxane 1a,b and the appropriate cyanoacetanilide (0.01 mol) in ethanol (50 mL) was stirred at room temperature in the presence of catalytic amount of potassium carbonate. The solutions turned red and then they were stirred at room temperature for 1 -5 hr depending on the BFO and the cyanoacetanilides. The residue obtained was triturated with waterand then extracted with dichloromethane. The organic phase was dried with anhydrous sodium sulphate and filtered. The solvent was removed in vacuo and the red-brown precipitate was recrystallized out from ethanol.
Yield (67%); mp 180˚C. IR (KBr, cm 3) 3-Amino-N-(4-chlorophenyl)-2-quinoxaline carboxamide 1,4-di-N-oxide 4c.
Yield (83%); mp 209˚C. IR (KBr, cm and dimidone (0.01 mol) in ethanol (50 mL) was stirred and heated at 60˚C, while ammonia gas was bubbled into the solution for 1 hr. The solution was stirred at room temperature for another 11 hr. The solvent was then removed and finally a yellow precipitate was obtained which was recrystallized out from ethanol. Yield 75%; mp. 267˚C -268˚C. IR (KBr, cm
